Key Takeaways:
- Despite the name, nothing is transplanted. A sample of tissue is processed and injected back into thinning areas, in the hope of supporting follicles that are still alive.
- No stem cell treatment for hair loss holds a UK licence. Depending on how the cells are processed, these products may be classified as Advanced Therapy Medicinal Products, and unlicensed medicines cannot legally be advertised to the public here.
- Fifteen published human studies exist, covering 653 patients. All reported improvement. Only five were randomised controlled trials, and the reviewers could not combine the results because the protocols varied so much.
- Where a benefit appeared, it appeared between three and six months and showed up as thicker existing hair.
- Bald areas do not respond, because the follicle has already gone.
- Platelet-rich plasma, exosomes and various “regenerative” injections are frequently sold under a stem cell label. They are separate products with separate evidence and separate legal status.
A stem cell hair transplant is not a hair transplant. No follicles are moved and no new hairline is created. Instead, cells obtained from a small sample of scalp or fat tissue are processed and injected into thinning areas of the scalp. The aim is to improve the activity of existing miniaturised follicles, not to create brand-new ones. Early human studies have reported changes in measures such as hair density and thickness, but the evidence remains limited and the procedures are not standardised.
What Is A Stem Cell?
A stem cell can make copies of itself or develop into a more specialised cell. Those two abilities, self-renewal and differentiation, are what make stem cells useful in regenerative medicine.
In the hair follicle, stem cells are held in the bulge, a small pocket partway down the follicle, where a reserve of cells sits ready to be called on for regrowth. The dermal papilla, a small cluster of cells sits at the base and has a different job: it sends the signals that regulate hair growth and shaft size.
Pattern hair loss does not immediately destroy the whole follicle. Bulge stem cells remain present in the balding scalp while certain progenitor-cell populations decline. At the same time, changes in the dermal papilla contribute to the gradual production of shorter, thinner hairs.
That leaves a biological opening for treatment while the follicle is still alive. It does not prove that any stem cell product currently being sold can reverse the process. Scarring alopecia is different because it involves irreversible damage to the follicle’s epithelial stem cells. Once that structure has been destroyed, stimulating it is no longer an option.
What Is A Stem Cell Hair Transplant?
It is an injection, not a transplant, and the borrowed name causes most of the confusion. A conventional hair transplant moves follicular grafts from the donor area into thinning or bald areas. A stem cell hair treatment does not. Tissue is collected, processed and injected into the scalp as a liquid. No follicles move. No hairline is constructed.
The tissue usually comes from one of two places. Small punch biopsies of hair-bearing scalp may be broken down mechanically to produce a cell-containing suspension. Alternatively, fat collected by liposuction may be processed to obtain its stromal vascular fraction.
The aim is to support what is already there. Follicular neogenesis means creating a new follicle where none existed. That has not been established as a clinical treatment in humans. Follicle rejuvenation means improving the output of a follicle that is still alive but miniaturised. The human studies measure changes such as hair density, count and shaft thickness, not confirmed creation of new follicular units.
Why The Research Is So Hard To Compare?
There is no standard method. The studies use different cell sources, preparation methods, treatment schedules and outcome measures. The 2023 systematic review in Cells therefore reviewed the results study by study rather than combining them in a meta-analysis. That makes the overall signal easier to see than the size of any true treatment effect. Most of the published work falls into three groups. A fourth product is often sold under the same label, although it belongs in a different category.
Hair Follicle-Derived Stem Cell Transplant
This is one of the better-studied methods. A few small punch biopsies are taken from the back of the scalp and mechanically processed in saline. The resulting suspension is injected into the thinning areas during the same appointment, without first growing the cells in a laboratory. In one such trial, eleven men with Norwood-Hamilton stage III to V hair loss took part. Each participant received the cell suspension in one part of the scalp and saline in another. After 23 weeks, hair density had increased by around 29% in the treated areas, compared with less than 1% in the control areas. The results were encouraging, but the study was too small to show whether the treatment works consistently. Several related studies have also involved some of the same researchers, so more evidence from independent groups is needed.
Adipose-Derived Stem Cell Transplant
This method uses fat rather than scalp tissue, so it begins with a small liposuction procedure. Fat is usually taken from the abdomen or flank and processed to isolate the stromal vascular fraction. Despite the name, this is not a preparation of stem cells alone. It contains several types of cell, and the mixture is injected into the scalp.
The conditioned medium is different again. It contains no living cells, only the fluid in which adipose-derived stem cells have been cultured. Researchers have injected this fluid into the scalp or applied it after microneedling. A small study in women with pattern hair loss reported an improvement after 12 weeks, but there was no control group.
The same broad approach has been tested in alopecia areata. A 2018 study of 20 patients reported hair growth and better hair-pull test results at three and six months. There was no untreated comparison group, and alopecia areata can improve on its own. It is also a different disease from pattern hair loss, so the result cannot be used as evidence that the treatment works for both.
Bone Marrow-Derived Stem Cell Transplant
This method collects mononuclear cells, a mixed population of blood cells that includes some early progenitor cells, from the patient’s own bone marrow. Patients are usually first given a course of granulocyte colony-stimulating factor, a medicine that pushes the bone marrow to release more of these cells into the bloodstream so they can be collected from a blood sample rather than the bone itself. The processed cells are then injected into the scalp.
The evidence is limited to one small comparative study, and the side-effect burden was notably higher than with the other methods: most participants who received the mobilising medication reported bone pain or a haematoma, alongside fatigue and chills. Here, the reported result depends as much on tolerating the preparation process as on the injection itself.
Stem Cell Educator Therapy
This treatment does not involve scalp injections. Blood is taken from the patient and processed to separate the mononuclear cells. These cells pass through a device containing cultured stem cells derived from donated cord blood before being returned to the patient. The donor cells remain inside the device. The process is intended to change the immune response involved in alopecia areata.
The 2015 study in BMC Medicine included nine people with severe alopecia areata. All received the treatment, and there was no comparison group. The researchers reported hair regrowth, but this was an early safety and feasibility study. It provides no evidence for treating androgenetic alopecia, which has a different cause.
Exosomes Are Not A Stem Cell Treatment
Exosomes are tiny vesicles that cells release to signal to each other, carrying proteins and RNA. They are derived from stem cells and they contain none. This distinction has become commercially important, because exosome products are now marketed more aggressively than anything else in the category, despite having the least regulatory backing of any product discussed here.
| Approach | What Is Injected | Strength of Human Evidence | What That Means in Practice |
|---|---|---|---|
| Hair Follicle-Derived Micrografts | Cells released from a punch of the patient’s own scalp | Moderate | Most-studied route. Several placebo-controlled trials, all small, with follow-up mostly under a year. |
| Dermal Sheath Cup Cells (Cultured) | Follicle cells expanded in a laboratory | Moderate, investigational | Studied under formal trial conditions in Japan. Not commercially available in the UK. |
| Adipose Stromal Vascular Fraction | Cell fraction separated from liposuctioned fat | Limited | Positive single-arm studies, weak controls, and adds liposuction to the procedure. |
| Adipose Stem Cell Conditioned Medium | The fluid stem cells were grown in, not the cells | Limited | Several small randomised trials with short follow-up. |
| Bone Marrow-Derived Cells | Mononuclear cells from marrow | Weak | One small comparative study. Notably high side-effect burden. |
| Stem Cell Educator Therapy | Patient’s own lymphocytes after contact with cord blood stem cells | Weak | One open-label study of nine patients, in alopecia areata only. |
| Exosomes | Vesicles released by cells. No cells present | None for hair loss | No approved product anywhere. Marketed regardless. |
| “Stem Cell PRP” | Platelet-rich plasma relabelled | Not applicable | PRP has its own evidence base. It is not a stem cell treatment. |
What Does A Stem Cell Hair Transplant Involve?
A biopsy, an hour or so of processing, and a round of injections. Protocols vary between clinics, so what follows describes the follicle-derived version, which is the most common.
Before the appointment, the scalp is assessed, ideally with trichoscopy so that density is
measured properly instead of estimated by eye. Ask for baseline photographs and the actual numbers, and keep a copy yourself. Without them there is no way to judge afterwards whether anything happened, and vague memories of how thin it used to look are easy to talk anybody out of.
On the day, 60 to 90 minutes
Local anaesthetic goes into the donor area, then a punch biopsy of a few millimetres, or a small liposuction if the adipose route is being used. The tissue is processed in the room. Injections are then placed across the thinning region, and some protocols do this without further anaesthetic.
First 48 hours
Soreness, redness and small bruises at the donor and injection sites. Pain during and just after injection is the complaint recorded most often across the published studies. Most people go back to work the same day or the next.
Weeks 1 to 4
Nothing visible. Early shedding, if it happens, indicates neither success nor failure. Follow whatever restrictions on exercise your treating clinician gives you.
Months 3 to 6
The window in which every study took its measurements. Any change appears here, and it appears as slightly denser, slightly thicker hair across an area that was thinning.
After 12 months
Largely unmapped, because published follow-up stops. You should expect to be told that another session is due, and you should expect there to be no data on what a second session adds.
What Are The Risks Of Stem Cell Hair Transplant?
The studies published so far have not identified many serious problems, but they have also been small and short. The 2023 Cells review covered 15 studies and 653 patients. That is not enough evidence to rule out uncommon or delayed complications.
- Injection-site reactions: Pain, redness, bruising, minor bleeding and scalp irritation were the most commonly reported problems. These generally settled without treatment.
- Purpura and haematoma: Some patients developed bleeding beneath the skin. One study reported a haematoma at the hairline following a fat-based injection.
- Liposuction-related risks: Treatments that use fat require a separate harvesting procedure. This adds possible pain, bruising, swelling, infection and contour irregularities at the donor site.
- Bone pain and fatigue: The bone marrow method involved granulocyte colony-stimulating factor before collection. Patients reported fatigue and chills, while bone pain or haematoma affected 80% of those treated in the single study using this method.
- Contamination and infection: Cell preparations must be collected, processed and stored under controlled conditions. Poor handling or inadequate sterility can introduce bacteria or other contaminants.
- Immune reactions: These may be possible when a product contains donor-derived cells or biological material. The risk depends on what the preparation contains and how it was produced.
- Unknown long-term effects: Most participants were followed for only a few months. The available studies cannot yet show whether uncommon or delayed problems occur.
The risks therefore depend partly on what is being injected, but also on how it was prepared. Patients should be told where the product was manufactured, what it contains and which regulatory authorisation covers its use.
What Is Normal And What Is Not Normal?
| Expected After Injection | Contact Your Clinic the Same Day |
|---|---|
| Soreness at donor and injection sites for a few days | Spreading redness, heat or swelling beyond the injection area |
| Small bruises or pinpoint bleeding | Pus, discharge or an offensive smell |
| Mild scalp tenderness or itching | Fever, chills or feeling systemically unwell |
| Tightness at the biopsy site | Severe or worsening pain instead of settling pain |
| No visible change for several weeks | A rash, breathlessness or facial swelling after injection |
In the UK, in an emergency: call 999 or attend the nearest A&E. For urgent advice that is not an emergency, call NHS 111. If you have arranged treatment through Longevita and are unsure who to speak to, contact your treating clinic first and our Client Support team at support@longevita.co.uk, who can help you reach the clinical team.
Stem Cell Hair Transplant: Can It Treat Baldness?
No. Thinning and bald are two different situations, and the treatment only has a plausible target in the first. Where follicles have miniaturised but survive, injected cells have produced measurable gains in density in trial conditions. Where the scalp is properly bald, the follicle has gone, and no injection tested so far has grown a replacement in a human being. The mouse studies people cite in support of the opposite are mouse studies.
You can see the same conclusion in who the trials recruited. Norwood stages 2 to 5, Ludwig 1 to 3, over and over. The men with a bare crown and the women with a widened part but reasonable coverage are the ones being studied. Anyone further along is generally excluded. One finding cuts against expectation. In the largest randomised trial in the field, improvement was greater in patients over 51, which the researchers put down to a bigger reserve of dormant follicles sitting in telogen, the hair follicle’s natural resting phase, and available to be nudged back into growth.
Is Stem Cell Hair Transplant Permanent?
We do not know. Current studies have not followed patients for long enough to show whether any improvement lasts permanently. A 2024 review of 12 randomised controlled trials found that most results were measured within three to twelve months. The authors noted that the effects may be temporary in some cases and called for longer follow-up.
Pattern hair loss also continues over time. Even if an injection improves some miniaturised follicles, untreated follicles may keep thinning. For now, claims of permanent regrowth after one session go beyond the published evidence.
What Are The Stem Cell Hair Transplant Results?
The studies published so far generally report some improvement in hair density or hair count. The problem is that they tested different preparations, used different doses and measured results at different points. Most were also small, and several had no control group.
The 2023 systematic review in Cells included 15 studies and 653 patients. Five were randomised controlled trials, while the rest included non-randomised trials, uncontrolled studies and retrospective case series. Follow-up was usually limited to a few months. The results suggest that some miniaturised follicles may respond to cell-based treatments. They do not yet show how noticeable that improvement will be, how long it will last or whether the treatment works consistently across different patients.
How Does It Compare To A Hair Transplant?
| Stem Cell Injection | FUE Hair Transplant | PRP | Minoxidil / Finasteride | |
|---|---|---|---|---|
| What It Does | May thicken surviving miniaturised follicles | Relocates living follicles into bald areas | May prolong the growth phase of existing follicles | Slows loss, may partially regrow |
| What It Does Not Do | Create hair where the follicle is gone | Stop ongoing loss in untreated areas | Create new follicles | Restore a lost hairline |
| Regulatory Status (UK) | Unlicensed, no approved product | Established surgical procedure | Autologous blood product, widely used | Licensed medicines |
| Evidence Base | Small trials, heterogeneous, short follow-up | Decades of outcome data | Moderate, protocol dependent | Strong for topical minoxidil |
| Longevity of Effect | Unknown, likely needs repeating | Transplanted follicles last, though loss elsewhere continues | Maintenance sessions needed | Only while you keep using it |
| Suitable For | Early to moderate thinning | Defined bald areas with adequate donor supply | Thinning alongside other treatment | Early loss and maintenance |
| Recovery | Injection soreness, back to work the same day | Days of visible healing, weeks of restrictions | Minimal | None |
The more useful comparison is against the treatments that already have a licence. Pattern hair loss carries on while you are trying something investigational, and months spent on an unproven injection are months in which follicles continue to miniaturise.
Is A Stem Cell Hair Transplant Available In The UK?
Not as an authorised medicinal treatment for hair loss. Depending on how the cells are processed and used, a cell-based product may be regulated as an Advanced Therapy Medicinal Product in the UK. The Human Tissue Authority oversees licensed activities involving human tissues and cells used as starting materials, while the MHRA regulates medicinal products, including ATMPs. We could not identify a stem-cell medicinal product authorised in the UK specifically for treating hair loss.
That does not mean such procedures are absent from the commercial market. The Prometheus study, a UK study of commercial stem-cell clinics, included providers advertising treatments for hair loss and found problematic marketing across 79% of the clinics examined. The authors concluded that the marketing information was often misleading and that prices could be excessive. Where an intervention is legally classified as a medicinal product, Regulation 279 of the Human Medicines Regulations 2012 prohibits publishing an advertisement for it unless the relevant marketing authorisation, registration or certificate is in force.
The picture is similar in the United States. The FDA says the only approved stem cell products are blood-forming cells derived from umbilical cord blood, used for certain blood disorders. No exosome product is FDA-approved.
Research into cell-based hair restoration is still active, but one problem keeps getting in the way. When dermal papilla cells are multiplied in conventional culture, they lose much of their ability to induce hair growth. Until researchers can produce enough cells without losing that function, hair multiplication remains a research goal rather than an available treatment.
When Will Stem Cell Hair Transplant Become Available?
No one can give a reliable date. The main problem is that dermal papilla cells quickly lose their ability to induce hair growth when multiplied in the laboratory. Researchers must also recreate the complex interaction between different cell types that forms a working hair follicle. These remain major barriers, according to a 2026 review of regenerative hair-loss treatments.
There has been progress. Dermal sheath cup cells have reached clinical trials in Japan, while researchers have grown human hair follicles in skin grafts placed on mice. Follicle banking is also available in the UK, but this only stores follicles for possible future use. None of these is currently an approved stem-cell treatment that patients can buy.
What Is Stem Cell Hair Transplant Cost?
Expect to pay more than you would for treatments with better evidence behind them. Pricing in this category often reflects novelty more than established outcomes, and the same Prometheus study identified excessive pricing as one of its concerns.
Three things determine whether a quoted figure means anything:
- What is actually being injected: Cells, conditioned medium, exosomes and platelet-rich plasma are four different products at four different price points, and all four are sold under this heading.
- How many sessions the price covers: Published protocols ranged from a single session to twelve weekly applications.
- What sits outside the quote: Consultation, follow-up trichoscopy, medication and any repeat session.
A price well below the local average usually signals a different and cheaper product carrying the same name, so it is worth asking the first question again.
Myths And What Is Actually True
| Claim | Verdict |
|---|---|
| “Stem cells clone your hair so donor supply no longer limits you” | Myth. Follicle cloning at clinical scale has not been achieved in humans. Cultured follicle cells lose their hair-inducing behaviour, and that remains the field’s central unsolved problem. |
| “It regrows hair on a completely bald scalp” | Myth. Trials recruited people with miniaturised follicles, not absent ones. |
| “It is permanent because it regenerates the follicle” | Myth. No long-term data exists, and the 2024 review of randomised trials notes effects may be temporary. |
| “The research is promising” | Largely true. Consistent positive signals across small studies, with controls too weak to confirm the cells are responsible. |
| “It is FDA approved” | Myth. The only approved stem cell products are cord blood derived, for blood disorders. |
| “It replaces the need for a hair transplant” | Myth. They address different problems. Injection may thicken what survives; surgery moves follicles into bald areas. |
| “Exosome therapy is a form of stem cell treatment” | It depends how you define it. Exosomes come from cells and contain none. No exosome product is approved anywhere. |
| “Stem cell therapy helps alopecia areata” | Early evidence only. One nine-patient open-label study, in a different condition. |
Cell-based hair treatment is a real field of research with a plausible mechanism and some consistent early signals. It is also, at present, an unlicensed product sold at premium prices on the strength of studies that would not support a licence application anywhere. Both descriptions are accurate, and the second is the one that should carry weight in a decision made this year.
Longevita does not arrange stem cell hair treatments. Where hair loss is early and follicles are still active, licensed medical treatment is the sensible starting point. Where areas have gone bald, FUE and DHI are the approaches with decades of outcome data behind them, and we can arrange a consultation with an independent treating clinician who will tell you honestly whether you are a candidate.
If you are weighing up a cell-based treatment elsewhere, our Client Support team at support@longevita.co.uk can help you put the questions above to the clinic. All clinical decisions rest with your treating clinician.
Frequently asked questions
Is a stem cell hair transplant safe?
No serious adverse events were reported across the 15 published studies, though the sample is too small for that to carry much weight. What was recorded was local and short lived: injection pain, bruising, redness and scalp tenderness. Safety also depends on where the product was prepared, since contamination is the main hazard with cell products made outside a controlled facility.
How many sessions will I need?
Most published protocols used more than one, and no clinic can give you a reliable number because no standard exists. The studies ranged from a single session to twelve weekly applications. Establish how many your quoted price includes before comparing it with anything.
How long does it take to see results?
Three to six months, if a change appears at all. That is the window in which the studies took their measurements. The first month brings nothing visible, and what eventually shows up is thicker existing hair.
Is a stem cell hair transplant better than PRP?
There is no evidence that it is. The two are often confused, partly because some clinics sell one as the other. PRP is a concentrate of your own platelets containing no stem cells, it has more clinical experience behind it, and it costs less. No head-to-head trial has shown either to outperform the other.
Can women have stem cell hair treatment?
Yes, and women took part in most of the trials. One randomised study found men and women responded similarly, which matters because the licensed options for female pattern hair loss are narrower than they are for men. The quality of the evidence is the same for both: early-stage and limited.
Can I have it at the same time as a hair transplant?
Some clinics offer it that way. No trial has shown the combination to outperform surgery alone, so if it is being added to a surgical quote, ask what it costs separately and what it is expected to contribute. Raise any combination with your treating clinician before agreeing to it.
Is stem cell hair transplant the same as hair cloning?
No. Hair cloning means multiplying follicle cells in a laboratory to produce new follicles, and it does not exist as an available treatment. What is sold today is a same-day injection of minimally processed cells intended to support follicles you already have.
Does it work for alopecia areata?
Too early to say. Alopecia areata is autoimmune, so cell-based work there targets the immune attack instead of the follicle. The published human evidence amounts to a nine patient open-label study and one small adipose-derived series. Licensed treatment for alopecia areata has advanced considerably in recent years, and a dermatologist is the right first conversation.
Is it available on the NHS?
No. Hair loss treatment is generally not NHS-funded on cosmetic grounds, and this treatment holds no UK licence in any case. A GP referral to a dermatologist can still be appropriate where hair loss is sudden, patchy or comes with other symptoms, because those patterns sometimes point to a treatable underlying cause.